C

Clearside Biomedical
D

CLSD

0.85230
USD
-0.00
(-0.49%)
مغلق
حجم التداول
3,801
الربح لكل سهم
-0
العائد الربحي
-
P/E
-2
حجم السوق
66,230,985
أصول ذات صلة
C
CRSP
-0.760
(-2.02%)
36.850 USD
C
CRVS
0.02000
(0.57%)
3.50000 USD
E
EDIT
-0.07000
(-4.32%)
1.55000 USD
N
NTLA
-0.30500
(-3.22%)
9.17000 USD
R
RGNX
-0.13000
(-1.32%)
9.73000 USD
S
SGMO
-0.02030
(-4.11%)
0.47370 USD
V
VCEL
-0.440
(-1.06%)
40.970 USD
المزيد
الأخبار المقالات

العنوان: Clearside Biomedical

القطاع: Healthcare
الصناعة: Biotechnology
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.